Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Toxigenic Clostridium difficile colonization in children
Journal of Pediatric Infectious Diseases, 10/30/09
Armin S et al. – The authors conclude that although the C. difficile colonization rate in the children is high (45.2%), the rate of toxigenic strains is low (4%). This may explain the low rate of C. difficile associated disease (CACD) in the population.
Related Articles
Molecular Epidemiology of Clostridium difficile over the Course of 10 Years in a Tertiary Care Hospital
Clinical Infectious Diseases, 10/16/09
Relevance Score: 67%
Clostridium difficile-related death rates in Texas 1999-2005
Journal of Infection, 10/06/09
Relevance Score: 67%
Bacteriophage-Mediated Toxin Gene Regulation in Clostridium difficile
Journal of Virology, 11/09/09
Relevance Score: 66%
Use of International Classification of Diseases, Ninth Revision, Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection
Infection Control and Hospital Epidemiology, 10/14/09
Relevance Score: 66%
Comparison of a rapid molecular-based method, BD GeneOhmTM Cdiff Assay to the most frequently used laboratory tests for the detection of toxin-producing C. difficile in diarrheal feces
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 66%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
The Journal of Headache and Pain, 11/25/09
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Emergency Influenza Drug
JAMA, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


